Clinical trial
A Prospective Multicenter Observational Study to Assess Long-term Outcome of Participants Who Have Received oNKord®
NCT05290662 is registered in ClinicalTrials.gov with Glycostem Therapeutics BV as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Multicenter Observational Study to Assess Long-term Outcome of Participants Who Have Received oNKord®
- Lead sponsor
- Glycostem Therapeutics BV
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 14, 2022
- Completion date
- March 31, 2028
- Enrollment
- 50 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
aml